BN Business News
Add your company to Business Communicator →

Regulacje i polityka gospodarcza · 16/11/2017

Becton Dickinson to Get Exclusive Patent License for Antineoplastic Drug Detection Kits

The National Institute of Allergy and Infectious Diseases is considering granting an exclusive patent commercialization license to Becton Dickinson to develop and commercialize Direct Reading Detection Kits for detecting surface contamination by antineoplastic drugs.

Source: Federal Register — All DocumentsOpen original release →